Cargando…
Surface-Modified Poly(l-lactide-co-glycolide) Scaffolds for the Treatment of Osteochondral Critical Size Defects—In Vivo Studies on Rabbits
Poly(l-lactide-co-glycolide) (PLGA) porous scaffolds were modified with collagen type I (PLGA/coll) or hydroxyapatite (PLGA/HAp) and implanted in rabbits osteochondral defects to check their biocompatibility and bone tissue regeneration potential. The scaffolds were fabricated using solvent casting/...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590021/ https://www.ncbi.nlm.nih.gov/pubmed/33066080 http://dx.doi.org/10.3390/ijms21207541 |
_version_ | 1783600711683014656 |
---|---|
author | Krok-Borkowicz, Małgorzata Reczyńska, Katarzyna Rumian, Łucja Menaszek, Elżbieta Orzelski, Maciej Malisz, Piotr Silmanowicz, Piotr Dobrzyński, Piotr Pamuła, Elżbieta |
author_facet | Krok-Borkowicz, Małgorzata Reczyńska, Katarzyna Rumian, Łucja Menaszek, Elżbieta Orzelski, Maciej Malisz, Piotr Silmanowicz, Piotr Dobrzyński, Piotr Pamuła, Elżbieta |
author_sort | Krok-Borkowicz, Małgorzata |
collection | PubMed |
description | Poly(l-lactide-co-glycolide) (PLGA) porous scaffolds were modified with collagen type I (PLGA/coll) or hydroxyapatite (PLGA/HAp) and implanted in rabbits osteochondral defects to check their biocompatibility and bone tissue regeneration potential. The scaffolds were fabricated using solvent casting/particulate leaching method. Their total porosity was 85% and the pore size was in the range of 250–320 µm. The physico-chemical properties of the scaffolds were evaluated using scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDX), X-ray diffractometry (XRD), X-ray photoelectron spectroscopy (XPS), Fourier transform infrared spectroscopy (FTIR), sessile drop, and compression tests. Three types of the scaffolds (unmodified PLGA, PLGA/coll, and PLGA/HAp) were implanted into the defects created in New Zealand rabbit femoral trochlears; empty defect acted as control. Samples were extracted after 1, 4, 12, and 26 weeks from the implantation, evaluated using micro-computed tomography (µCT), and stained by Masson–Goldner and hematoxylin-eosin. The results showed that the proposed method is suitable for fabrication of highly porous PLGA scaffolds. Effective deposition of both coll and HAp was confirmed on all surfaces of the pores through the entire scaffold volume. In the in vivo model, PLGA and PLGA/HAp scaffolds enhanced tissue ingrowth as shown by histological and morphometric analyses. Bone formation was the highest for PLGA/HAp scaffolds as evidenced by µCT. Neo-tissue formation in the defect site was well correlated with degradation kinetics of the scaffold material. Interestingly, around PLGA/coll extensive inflammation and inhibited tissue healing were detected, presumably due to immunological response of the host towards collagen of bovine origin. To summarize, PLGA scaffolds modified with HAp are the most promising materials for bone tissue regeneration. |
format | Online Article Text |
id | pubmed-7590021 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75900212020-10-29 Surface-Modified Poly(l-lactide-co-glycolide) Scaffolds for the Treatment of Osteochondral Critical Size Defects—In Vivo Studies on Rabbits Krok-Borkowicz, Małgorzata Reczyńska, Katarzyna Rumian, Łucja Menaszek, Elżbieta Orzelski, Maciej Malisz, Piotr Silmanowicz, Piotr Dobrzyński, Piotr Pamuła, Elżbieta Int J Mol Sci Article Poly(l-lactide-co-glycolide) (PLGA) porous scaffolds were modified with collagen type I (PLGA/coll) or hydroxyapatite (PLGA/HAp) and implanted in rabbits osteochondral defects to check their biocompatibility and bone tissue regeneration potential. The scaffolds were fabricated using solvent casting/particulate leaching method. Their total porosity was 85% and the pore size was in the range of 250–320 µm. The physico-chemical properties of the scaffolds were evaluated using scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDX), X-ray diffractometry (XRD), X-ray photoelectron spectroscopy (XPS), Fourier transform infrared spectroscopy (FTIR), sessile drop, and compression tests. Three types of the scaffolds (unmodified PLGA, PLGA/coll, and PLGA/HAp) were implanted into the defects created in New Zealand rabbit femoral trochlears; empty defect acted as control. Samples were extracted after 1, 4, 12, and 26 weeks from the implantation, evaluated using micro-computed tomography (µCT), and stained by Masson–Goldner and hematoxylin-eosin. The results showed that the proposed method is suitable for fabrication of highly porous PLGA scaffolds. Effective deposition of both coll and HAp was confirmed on all surfaces of the pores through the entire scaffold volume. In the in vivo model, PLGA and PLGA/HAp scaffolds enhanced tissue ingrowth as shown by histological and morphometric analyses. Bone formation was the highest for PLGA/HAp scaffolds as evidenced by µCT. Neo-tissue formation in the defect site was well correlated with degradation kinetics of the scaffold material. Interestingly, around PLGA/coll extensive inflammation and inhibited tissue healing were detected, presumably due to immunological response of the host towards collagen of bovine origin. To summarize, PLGA scaffolds modified with HAp are the most promising materials for bone tissue regeneration. MDPI 2020-10-13 /pmc/articles/PMC7590021/ /pubmed/33066080 http://dx.doi.org/10.3390/ijms21207541 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Krok-Borkowicz, Małgorzata Reczyńska, Katarzyna Rumian, Łucja Menaszek, Elżbieta Orzelski, Maciej Malisz, Piotr Silmanowicz, Piotr Dobrzyński, Piotr Pamuła, Elżbieta Surface-Modified Poly(l-lactide-co-glycolide) Scaffolds for the Treatment of Osteochondral Critical Size Defects—In Vivo Studies on Rabbits |
title | Surface-Modified Poly(l-lactide-co-glycolide) Scaffolds for the Treatment of Osteochondral Critical Size Defects—In Vivo Studies on Rabbits |
title_full | Surface-Modified Poly(l-lactide-co-glycolide) Scaffolds for the Treatment of Osteochondral Critical Size Defects—In Vivo Studies on Rabbits |
title_fullStr | Surface-Modified Poly(l-lactide-co-glycolide) Scaffolds for the Treatment of Osteochondral Critical Size Defects—In Vivo Studies on Rabbits |
title_full_unstemmed | Surface-Modified Poly(l-lactide-co-glycolide) Scaffolds for the Treatment of Osteochondral Critical Size Defects—In Vivo Studies on Rabbits |
title_short | Surface-Modified Poly(l-lactide-co-glycolide) Scaffolds for the Treatment of Osteochondral Critical Size Defects—In Vivo Studies on Rabbits |
title_sort | surface-modified poly(l-lactide-co-glycolide) scaffolds for the treatment of osteochondral critical size defects—in vivo studies on rabbits |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590021/ https://www.ncbi.nlm.nih.gov/pubmed/33066080 http://dx.doi.org/10.3390/ijms21207541 |
work_keys_str_mv | AT krokborkowiczmałgorzata surfacemodifiedpolyllactidecoglycolidescaffoldsforthetreatmentofosteochondralcriticalsizedefectsinvivostudiesonrabbits AT reczynskakatarzyna surfacemodifiedpolyllactidecoglycolidescaffoldsforthetreatmentofosteochondralcriticalsizedefectsinvivostudiesonrabbits AT rumianłucja surfacemodifiedpolyllactidecoglycolidescaffoldsforthetreatmentofosteochondralcriticalsizedefectsinvivostudiesonrabbits AT menaszekelzbieta surfacemodifiedpolyllactidecoglycolidescaffoldsforthetreatmentofosteochondralcriticalsizedefectsinvivostudiesonrabbits AT orzelskimaciej surfacemodifiedpolyllactidecoglycolidescaffoldsforthetreatmentofosteochondralcriticalsizedefectsinvivostudiesonrabbits AT maliszpiotr surfacemodifiedpolyllactidecoglycolidescaffoldsforthetreatmentofosteochondralcriticalsizedefectsinvivostudiesonrabbits AT silmanowiczpiotr surfacemodifiedpolyllactidecoglycolidescaffoldsforthetreatmentofosteochondralcriticalsizedefectsinvivostudiesonrabbits AT dobrzynskipiotr surfacemodifiedpolyllactidecoglycolidescaffoldsforthetreatmentofosteochondralcriticalsizedefectsinvivostudiesonrabbits AT pamułaelzbieta surfacemodifiedpolyllactidecoglycolidescaffoldsforthetreatmentofosteochondralcriticalsizedefectsinvivostudiesonrabbits |